PT  - JOURNAL ARTICLE
AU  - Lazarus, Jeffrey V
AU  - Ratzan, Scott
AU  - Palayew, Adam
AU  - Gostin, Lawrence O
AU  - Larson, Heidi J
AU  - Rabin, Kenneth
AU  - Kimball, Spencer
AU  - El-Mohandes, Ayman
TI  - Hesitant or not? A global survey of potential acceptance of a COVID-19 vaccine
AID  - 10.1101/2020.08.23.20180307
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.23.20180307
4099  - http://medrxiv.org/content/early/2020/08/25/2020.08.23.20180307.short
4100  - http://medrxiv.org/content/early/2020/08/25/2020.08.23.20180307.full
AB  - A number of COVID-19 vaccines are under development, with one or more possibly becoming available in 2021. We conducted a global survey in June 2020 of 13,426 people in 19 countries to determine potential acceptance rates of a COVID-19 vaccine and factors influencing acceptance. We ran univariate logistic regressions to examine the associations with demographic variables. 71.5% reported they would be very or somewhat likely to take a COVID-19 vaccine; 61.4% reported they would accept their employer’s recommendation to take a COVID-19 vaccine. Differences in acceptance across countries ranged from almost 9 in 10 (China) to fewer than 6 in 10 (Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine, and take their employer’s advice to do so. Targeted interventions addressing age, sex, income, and education level are required to increase and sustain public acceptance of a COVID-19 vaccine.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe City University of New York Foundation, Bocconi University, Dr Jonathan Fielding, the United States Council for International Business Foundation, and Dr Kenneth Rabin. Emerson College, USA, was the funding recipient.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Emerson College, USA (IRB protocol number 20-023-F-E-6/12), with an expiration date of 11 June 2021. The online questionnaire was administered by Emerson College to gather information from respondents after obtaining their written, informed consent about the survey and this project. No personally identifiable information was collected or stored.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data and code to reproduce this analysis can be found at https://osf.io/kzq69/. https://osf.io/kzq69/